4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001209191-23-016455
Options or other derivatives
- Director acquired 2,870 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Coleman Mark Director | 2023-03-02 | Grant or award · Stock Option (Right to Buy) | +2,870 | 2,870 | D | ||
Loading xslF345X03/doc4.xml…